University of Aberdeen
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1495-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.abdn.ac.uk
Clinical Trials
171
Active:1
Completed:104
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:4
Phase 2:6
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (99 trials with phase data)• Click on a phase to view related trials
Not Applicable
84 (84.8%)Phase 2
6 (6.1%)Phase 1
4 (4.0%)Phase 3
2 (2.0%)Phase 4
2 (2.0%)Early Phase 1
1 (1.0%)Neural Correlates of Autistic Individuals With Anorexia Nervosa
Recruiting
- Conditions
- AutismAnorexia Nervosa
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- University of Aberdeen
- Target Recruit Count
- 50
- Registration Number
- NCT07098156
- Locations
- 🇬🇧
Lilian Sutton Building, Aberdeen, Aberdeen City, United Kingdom
🇬🇧NHS Grampian Eating Disorder Services, Aberdeen, Aberdeen City, United Kingdom
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity
Not Applicable
Not yet recruiting
- Conditions
- Breast Cancer
- Interventions
- Drug: Sodium-glucose transport-2 (SGLT-2) inhibitorsOther: Standard medical treatment
- First Posted Date
- 2025-07-17
- Last Posted Date
- 2025-07-23
- Lead Sponsor
- University of Aberdeen
- Target Recruit Count
- 70
- Registration Number
- NCT07070765
- Locations
- 🇬🇧
University of Aberdeen, Aberdeen, United Kingdom
Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric Restriction
Not Applicable
Recruiting
- Conditions
- Overweight and Obese AdultsHealthy
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- University of Aberdeen
- Target Recruit Count
- 75
- Registration Number
- NCT07065643
- Locations
- 🇬🇧
Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom
Rebalancing the Fat Content of the Heart and Muscles
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Drug: Semaglutide administration plus dietary counselling and physical activity encouragementDrug: Semaglutide plus a personalised and supervised program of resistance and endurance training
- First Posted Date
- 2025-07-15
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- University of Aberdeen
- Target Recruit Count
- 60
- Registration Number
- NCT07065383
How Healthy Are Your Oats?
Not Applicable
Recruiting
- Conditions
- Mycotoxin Biomonitoring
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- University of Aberdeen
- Target Recruit Count
- 16
- Registration Number
- NCT07050680
- Locations
- 🇬🇧
Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom
- Prev
- 1
- 2
- 3
- 4
- 5
- 35
- Next
News
GLP-1 Drugs Show Promise for Asthma Control in Obese Patients Beyond Weight Loss Benefits
A UK study of over 60,000 patients found that GLP-1 receptor agonists significantly improved asthma control scores in obese individuals with asthma compared to matched controls.